共 51 条
Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder
被引:16
作者:
Long, Kexin
[1
]
Wan, Changmin
[2
]
Xiang, Yaqin
[1
]
Liu, Jiabin
[1
]
Xu, Qian
[1
]
Sun, Qiying
[1
]
Wang, Zhiqin
[1
]
Tian, Yun
[1
]
Fang, Liangjuan
[1
]
Yang, Yang
[1
]
Yan, Xinxiang
[1
]
Tang, Beisha
[1
,3
,4
]
Guo, Jifeng
[1
,3
,4
]
机构:
[1] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Peoples R China
[2] Changsha Cent Hosp, Dept Neurol, Changsha, Peoples R China
[3] Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[4] Cent South Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Parkinson's disease;
sleep disorders;
probable rapid eye movement sleep behavior disorder;
motor symptoms;
non-motor symptoms;
REM-SLEEP;
OLFACTORY DYSFUNCTION;
DAYTIME SLEEPINESS;
NONMOTOR SYMPTOMS;
SCALE;
VALIDATION;
NEURODEGENERATION;
QUESTIONNAIRE;
CONNECTIVITY;
PATHOLOGY;
D O I:
10.3389/fneur.2020.00979
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Objective:To investigate the clinical features and factors associated with Parkinson's disease (PD) patients with probable rapid eye movement sleep behavior disorder (PD-pRBD). Methods:A total of 2,440 patients with clinically established or clinically probable PD were divided into two groups: PD-pRBD and PD without pRBD (PD-NRBD), according to the RBD questionnaire-Hong Kong. Data collection included demographic data, basic clinical history, and motor and non-motor symptoms. Based on the onset time of pRBD and the motor symptoms in PD, PD-pRBD patients were further divided into the pRBD prior to PD (PD-prRBD) group and the pRBD posterior to PD (PD-poRBD) group. Clinical features were compared between the PD-pRBD and PD-NRBD groups, as well as the PD-prRBD and PD-poRBD groups. The associated factors of pRBD were also explored. Results:The prevalence of pRBD was 41.4% (1,010 out of the total of 2,440) in our PD cohort. Further, compared with the PD-NRBD group, the PD-pRBD group had longer disease duration and more severe motor symptoms. Moreover, the PD-pRBD group had significantly higher levodopa equivalent daily dose and a higher ratio of dyskinesia, wearing-off, and offset of the Hoehn-Yahr stage. The scores on the non-motor symptom rating scale (NMSS), cognitive impairment, Parkinson's disease sleep scale (PDSS), excessive daytime sleepiness, constipation, hyposmia, depression, and the 39-item Parkinson's disease questionnaire also appeared worse in the PD-pRBD group. Significant differences in the educational level, disease duration, disease progression, Unified Parkinson's Disease Rating Scale (UPDRS)-II, UPDRS-III, tremor, rigidity, bradykinesia, posture gait, frozen gait, levodopa equivalent daily dose, dyskinesia, wearing-off, Hoehn-Yahr stage, NMSS-6, PDSS, and communication score widely existed between the PD-prRBD and PD-poRBD groups. Late-onset PD, long disease duration, high UPDRS-I score, high NMSS-4 score, low PDSS score, constipation, and hyposmia were all identified as the risk factors for PD-pRBD. Conclusions:Compared with the PD-NRBD group, the PD-pRBD group may have more severe motor symptoms, motor complications, and non-motor symptoms as well as a substandard quality of life. Further, late-onset PD, long disease duration, high UPDRS-I score, high NMSS-4 score, low PDSS score, constipation, and hyposmia can be risk factors for RBD in PD. Differences also occurred between the PD-prRBD and PD-poRBD groups.
引用
收藏
页数:10
相关论文